BPDCN

Blastic plasmacytoid dendritic neoplasm is commonly misdiagnosed as various forms of leukemia.

Click here to answer this week's poll.

ICYMI, this week we had stories about blastic plasmacytoid dendritic cell neoplasm, epidermolysis bullosa, an interview with Seth Matarasso, MD, and more.

Blastic plasmacytoid dendritis cell neoplasm is a rare and aggressive form of cancer that usually makes its appearance in the form of red to violet papules and plaques.

An expert weighs in on the latest updates in clinical research about this rare blood cancer that often manifests with cutaneous lesions.

A world leader in BPDCN explains how using social media can enhance dermatologists’ knowledge about this rare form of aggressive blood cancer.

A 13-year-old boy presenting an asymptotic dark violaceous infiltrated nodular lesion located on the left cheek was diagnosed with blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and aggressive hematologic malignancy that often presents with skin manifestations.

Click here to answer our weekly poll.

Rare aggressive cutaneous lymphoma puts patients at risk of thyroid and non-lymphocytic leukemia second primary malignancies, researchers say.

Researchers are looking at treating blastic plasmacytoid dendritic cell neoplasm (BPDCN), an aggressive hematolymphoid malignancy, with investigational agents equipped with different mechanisms of action, including XmAb14045 and IMGN632.